Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depression | 22 | 2017 | 436 | 4.450 |
Why?
|
Macaca fascicularis | 45 | 2019 | 401 | 4.040 |
Why?
|
Sertraline | 8 | 2017 | 27 | 3.730 |
Why?
|
Serotonin Uptake Inhibitors | 9 | 2017 | 37 | 3.210 |
Why?
|
Behavior, Animal | 16 | 2015 | 262 | 2.870 |
Why?
|
Stress, Psychological | 18 | 2015 | 218 | 2.570 |
Why?
|
Disease Models, Animal | 31 | 2018 | 1040 | 2.320 |
Why?
|
Depressive Disorder | 7 | 2016 | 76 | 2.200 |
Why?
|
Animals | 83 | 2021 | 7694 | 2.150 |
Why?
|
Diet, Mediterranean | 4 | 2019 | 32 | 1.630 |
Why?
|
Aging | 10 | 2017 | 953 | 1.410 |
Why?
|
Hippocampus | 6 | 2016 | 173 | 1.370 |
Why?
|
Coronary Artery Disease | 8 | 2015 | 397 | 1.360 |
Why?
|
Energy Intake | 2 | 2019 | 128 | 1.300 |
Why?
|
Social Behavior | 8 | 2013 | 65 | 1.290 |
Why?
|
Motor Activity | 7 | 2016 | 327 | 1.290 |
Why?
|
Antidepressive Agents | 4 | 2017 | 77 | 1.250 |
Why?
|
Primates | 11 | 2021 | 111 | 1.230 |
Why?
|
Female | 74 | 2021 | 20126 | 1.180 |
Why?
|
Obesity | 9 | 2021 | 1164 | 1.040 |
Why?
|
Monkey Diseases | 3 | 2014 | 18 | 0.960 |
Why?
|
Ovariectomy | 10 | 2018 | 152 | 0.940 |
Why?
|
Hydrocortisone | 10 | 2013 | 61 | 0.850 |
Why?
|
Aggression | 8 | 2007 | 30 | 0.840 |
Why?
|
Heart Rate | 8 | 2017 | 337 | 0.820 |
Why?
|
Haplorhini | 7 | 2019 | 67 | 0.810 |
Why?
|
Energy Metabolism | 3 | 2019 | 147 | 0.800 |
Why?
|
Random Allocation | 10 | 2018 | 220 | 0.790 |
Why?
|
Postmenopause | 5 | 2011 | 409 | 0.790 |
Why?
|
Progesterone | 8 | 2014 | 95 | 0.790 |
Why?
|
Ethanol | 6 | 2007 | 187 | 0.740 |
Why?
|
Hierarchy, Social | 7 | 2013 | 24 | 0.740 |
Why?
|
Estradiol | 5 | 2018 | 129 | 0.740 |
Why?
|
Dominance-Subordination | 9 | 2005 | 15 | 0.730 |
Why?
|
Premenopause | 2 | 2017 | 41 | 0.720 |
Why?
|
Soybeans | 2 | 2014 | 25 | 0.710 |
Why?
|
Atherosclerosis | 5 | 2015 | 770 | 0.710 |
Why?
|
Isoflavones | 2 | 2014 | 66 | 0.690 |
Why?
|
Muscle, Skeletal | 4 | 2019 | 514 | 0.690 |
Why?
|
Carotid Artery Diseases | 2 | 2017 | 114 | 0.670 |
Why?
|
Neurons | 3 | 2013 | 413 | 0.660 |
Why?
|
Brain | 7 | 2018 | 971 | 0.660 |
Why?
|
Mammary Glands, Human | 1 | 2018 | 15 | 0.650 |
Why?
|
Heart | 3 | 2018 | 182 | 0.650 |
Why?
|
Fatty Liver | 1 | 2019 | 67 | 0.650 |
Why?
|
Carotid Artery, Common | 1 | 2017 | 39 | 0.600 |
Why?
|
Alcohol Drinking | 4 | 2004 | 257 | 0.580 |
Why?
|
Synapses | 2 | 2017 | 83 | 0.580 |
Why?
|
Endotoxemia | 1 | 2016 | 7 | 0.550 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 71 | 0.530 |
Why?
|
Housing, Animal | 2 | 2014 | 23 | 0.520 |
Why?
|
Sarcopenia | 1 | 2016 | 60 | 0.520 |
Why?
|
Thyroid Hormones | 1 | 2014 | 5 | 0.500 |
Why?
|
Estrogen Replacement Therapy | 4 | 2007 | 188 | 0.490 |
Why?
|
Animals, Laboratory | 1 | 2014 | 5 | 0.490 |
Why?
|
Serotonin | 5 | 2004 | 37 | 0.480 |
Why?
|
Soybean Proteins | 1 | 2014 | 64 | 0.480 |
Why?
|
Dentate Gyrus | 1 | 2014 | 6 | 0.470 |
Why?
|
Adipose Tissue | 4 | 2016 | 345 | 0.470 |
Why?
|
Biogenic Monoamines | 1 | 2013 | 4 | 0.470 |
Why?
|
Myocardium | 2 | 2018 | 196 | 0.470 |
Why?
|
Neuroglia | 1 | 2014 | 30 | 0.460 |
Why?
|
CA1 Region, Hippocampal | 1 | 2014 | 26 | 0.460 |
Why?
|
Social Isolation | 3 | 2013 | 43 | 0.460 |
Why?
|
Hemorrhage | 1 | 2014 | 101 | 0.450 |
Why?
|
Neuropil | 1 | 2013 | 2 | 0.450 |
Why?
|
Imitative Behavior | 1 | 2013 | 2 | 0.440 |
Why?
|
Cholesterol | 3 | 2011 | 251 | 0.440 |
Why?
|
Dexamethasone | 6 | 2013 | 44 | 0.430 |
Why?
|
Body Composition | 5 | 2019 | 384 | 0.430 |
Why?
|
Coronary Vessels | 2 | 2015 | 158 | 0.420 |
Why?
|
Photic Stimulation | 1 | 2013 | 159 | 0.420 |
Why?
|
Analysis of Variance | 6 | 2017 | 470 | 0.410 |
Why?
|
Cardiovascular Diseases | 4 | 2019 | 1133 | 0.410 |
Why?
|
Fatty Acids | 2 | 2019 | 97 | 0.400 |
Why?
|
Hydroxyindoleacetic Acid | 4 | 2015 | 17 | 0.400 |
Why?
|
Nervous System | 1 | 2011 | 15 | 0.400 |
Why?
|
Social Environment | 3 | 2020 | 80 | 0.400 |
Why?
|
Risk Factors | 11 | 2017 | 3876 | 0.380 |
Why?
|
Gait | 1 | 2011 | 130 | 0.380 |
Why?
|
Women's Health | 2 | 2009 | 235 | 0.370 |
Why?
|
Adaptation, Biological | 1 | 2009 | 8 | 0.350 |
Why?
|
Macaca | 8 | 2015 | 26 | 0.340 |
Why?
|
Lipids | 1 | 2011 | 226 | 0.340 |
Why?
|
Pituitary-Adrenal System | 6 | 2008 | 24 | 0.330 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2007 | 93 | 0.330 |
Why?
|
Hypothalamo-Hypophyseal System | 6 | 2008 | 34 | 0.330 |
Why?
|
Intra-Abdominal Fat | 1 | 2009 | 66 | 0.330 |
Why?
|
Ovary | 5 | 2014 | 57 | 0.320 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 122 | 0.320 |
Why?
|
Humans | 26 | 2021 | 32297 | 0.310 |
Why?
|
Heart Failure | 1 | 2014 | 630 | 0.310 |
Why?
|
Estrogens | 7 | 2013 | 174 | 0.300 |
Why?
|
Arousal | 3 | 2005 | 19 | 0.280 |
Why?
|
Receptor, Serotonin, 5-HT1A | 1 | 2006 | 4 | 0.280 |
Why?
|
Central Nervous System Depressants | 1 | 2007 | 63 | 0.270 |
Why?
|
Menopause | 4 | 2013 | 92 | 0.270 |
Why?
|
Alcoholism | 1 | 2007 | 102 | 0.270 |
Why?
|
Longitudinal Studies | 3 | 2017 | 786 | 0.260 |
Why?
|
Cell Count | 2 | 2013 | 52 | 0.260 |
Why?
|
Dopamine | 2 | 1998 | 232 | 0.250 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 190 | 0.250 |
Why?
|
Mammary Glands, Animal | 1 | 2004 | 47 | 0.240 |
Why?
|
Ethinyl Estradiol-Norgestrel Combination | 1 | 2004 | 4 | 0.240 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2004 | 7 | 0.240 |
Why?
|
Mood Disorders | 1 | 2004 | 20 | 0.230 |
Why?
|
Contraceptives, Oral | 1 | 2004 | 22 | 0.230 |
Why?
|
Diet | 4 | 2021 | 384 | 0.230 |
Why?
|
Gonadal Steroid Hormones | 1 | 2004 | 29 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 1345 | 0.230 |
Why?
|
Body Mass Index | 4 | 2013 | 921 | 0.220 |
Why?
|
Object Attachment | 1 | 2002 | 2 | 0.220 |
Why?
|
Plant Preparations | 1 | 2003 | 21 | 0.220 |
Why?
|
Organ Size | 2 | 2015 | 220 | 0.220 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 34 | 0.220 |
Why?
|
Endometrium | 1 | 2004 | 175 | 0.220 |
Why?
|
Cytokines | 2 | 2015 | 262 | 0.210 |
Why?
|
Longevity | 2 | 2020 | 24 | 0.210 |
Why?
|
Cognition | 2 | 2004 | 551 | 0.200 |
Why?
|
Alzheimer Disease | 2 | 2018 | 351 | 0.200 |
Why?
|
Synaptic Transmission | 1 | 2003 | 116 | 0.200 |
Why?
|
Administration, Oral | 2 | 2015 | 185 | 0.200 |
Why?
|
Placebos | 2 | 2014 | 66 | 0.190 |
Why?
|
Mammals | 1 | 2020 | 11 | 0.180 |
Why?
|
Biomedical Research | 2 | 2015 | 169 | 0.180 |
Why?
|
Inflammation | 3 | 2015 | 542 | 0.180 |
Why?
|
Diet, Atherogenic | 3 | 2013 | 61 | 0.170 |
Why?
|
Receptors, Dopamine D2 | 2 | 1998 | 79 | 0.170 |
Why?
|
Mitochondria, Muscle | 1 | 2019 | 18 | 0.170 |
Why?
|
Gene Expression | 2 | 2018 | 345 | 0.170 |
Why?
|
Comorbidity | 2 | 2014 | 572 | 0.170 |
Why?
|
Health Status | 1 | 2002 | 402 | 0.170 |
Why?
|
Contraceptives, Oral, Sequential | 1 | 1998 | 1 | 0.160 |
Why?
|
Diastole | 1 | 2018 | 100 | 0.160 |
Why?
|
Treatment Outcome | 2 | 2017 | 3358 | 0.160 |
Why?
|
Homeostasis | 1 | 2018 | 133 | 0.160 |
Why?
|
Carrier Proteins | 3 | 2006 | 141 | 0.160 |
Why?
|
Time Factors | 5 | 2018 | 2181 | 0.150 |
Why?
|
Male | 13 | 2017 | 19488 | 0.150 |
Why?
|
Vagus Nerve | 1 | 2017 | 29 | 0.150 |
Why?
|
Equilin | 1 | 1997 | 1 | 0.150 |
Why?
|
Dendrites | 1 | 1997 | 16 | 0.150 |
Why?
|
Circadian Rhythm | 3 | 2013 | 44 | 0.150 |
Why?
|
Anxiety | 2 | 2015 | 185 | 0.150 |
Why?
|
Lewy Body Disease | 1 | 2017 | 5 | 0.150 |
Why?
|
Inheritance Patterns | 1 | 2017 | 11 | 0.150 |
Why?
|
Hot Flashes | 1 | 2017 | 48 | 0.150 |
Why?
|
Reference Values | 1 | 2017 | 255 | 0.150 |
Why?
|
Nerve Degeneration | 1 | 2017 | 15 | 0.150 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2014 | 41 | 0.150 |
Why?
|
Neostriatum | 1 | 2017 | 22 | 0.140 |
Why?
|
Insulin Resistance | 2 | 2019 | 460 | 0.140 |
Why?
|
Apolipoprotein E4 | 1 | 2017 | 62 | 0.140 |
Why?
|
Adrenocorticotropic Hormone | 3 | 2005 | 22 | 0.140 |
Why?
|
Calcium | 1 | 2018 | 310 | 0.140 |
Why?
|
Extracellular Matrix | 1 | 2018 | 245 | 0.140 |
Why?
|
Bacterial Translocation | 1 | 2016 | 8 | 0.140 |
Why?
|
Atlases as Topic | 1 | 2016 | 9 | 0.140 |
Why?
|
Phenotype | 3 | 2015 | 656 | 0.140 |
Why?
|
Intestines | 1 | 2016 | 61 | 0.140 |
Why?
|
Menstrual Cycle | 4 | 2002 | 59 | 0.130 |
Why?
|
Matrix Metalloproteinases, Secreted | 1 | 2015 | 3 | 0.130 |
Why?
|
Menisci, Tibial | 1 | 2015 | 25 | 0.130 |
Why?
|
Brain Mapping | 1 | 2016 | 178 | 0.130 |
Why?
|
Iliac Artery | 1 | 2015 | 49 | 0.130 |
Why?
|
Triiodothyronine | 1 | 2014 | 7 | 0.120 |
Why?
|
Thyrotropin | 1 | 2014 | 9 | 0.120 |
Why?
|
Lactalbumin | 1 | 2014 | 10 | 0.120 |
Why?
|
Caseins | 1 | 2014 | 14 | 0.120 |
Why?
|
Thyroxine | 1 | 2014 | 16 | 0.120 |
Why?
|
Upper Extremity | 1 | 2015 | 58 | 0.120 |
Why?
|
Thyroid Gland | 1 | 2014 | 15 | 0.120 |
Why?
|
Rotator Cuff | 1 | 2015 | 72 | 0.120 |
Why?
|
Blood Chemical Analysis | 1 | 2014 | 23 | 0.120 |
Why?
|
Dietary Proteins | 1 | 2014 | 51 | 0.120 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 89 | 0.120 |
Why?
|
Thrombocytopenia | 1 | 2014 | 32 | 0.120 |
Why?
|
Models, Animal | 4 | 2016 | 164 | 0.120 |
Why?
|
Body Weights and Measures | 1 | 2014 | 23 | 0.120 |
Why?
|
Cholesterol, HDL | 2 | 2013 | 176 | 0.120 |
Why?
|
Knee Joint | 1 | 2015 | 142 | 0.120 |
Why?
|
Microfilament Proteins | 1 | 2014 | 35 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 244 | 0.110 |
Why?
|
DNA Methylation | 1 | 2015 | 142 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 1428 | 0.110 |
Why?
|
Geriatrics | 1 | 2015 | 98 | 0.110 |
Why?
|
Vision, Ocular | 1 | 2013 | 33 | 0.110 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2013 | 11 | 0.110 |
Why?
|
Stereotaxic Techniques | 1 | 2013 | 23 | 0.110 |
Why?
|
Body Weight | 2 | 2016 | 311 | 0.110 |
Why?
|
Receptors, Bombesin | 1 | 2013 | 8 | 0.110 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2013 | 7 | 0.110 |
Why?
|
Echocardiography | 1 | 2014 | 157 | 0.110 |
Why?
|
Nerve Fibers | 1 | 2013 | 37 | 0.110 |
Why?
|
Steroids | 1 | 2013 | 38 | 0.110 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 133 | 0.110 |
Why?
|
Antigens, CD | 1 | 2013 | 105 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 675 | 0.110 |
Why?
|
Sex Factors | 3 | 2014 | 674 | 0.110 |
Why?
|
Video Recording | 1 | 2013 | 57 | 0.110 |
Why?
|
Pruritus | 1 | 2013 | 64 | 0.110 |
Why?
|
Aged | 5 | 2017 | 10398 | 0.100 |
Why?
|
Osteoarthritis | 1 | 2013 | 78 | 0.100 |
Why?
|
Cercopithecidae | 1 | 2011 | 10 | 0.100 |
Why?
|
Spinal Cord | 1 | 2013 | 139 | 0.100 |
Why?
|
Neurobiology | 1 | 2011 | 3 | 0.100 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2012 | 111 | 0.100 |
Why?
|
Macaca mulatta | 1 | 2013 | 332 | 0.100 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2013 | 2296 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2011 | 110 | 0.090 |
Why?
|
Anthropometry | 2 | 2009 | 86 | 0.090 |
Why?
|
Shoulder Joint | 1 | 2013 | 126 | 0.090 |
Why?
|
Hormone Replacement Therapy | 3 | 2010 | 89 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2013 | 422 | 0.090 |
Why?
|
Cross-Over Studies | 2 | 2007 | 101 | 0.080 |
Why?
|
Behavior | 1 | 2008 | 31 | 0.080 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2008 | 11 | 0.080 |
Why?
|
Endometrial Hyperplasia | 1 | 2008 | 14 | 0.080 |
Why?
|
Emotions | 1 | 2008 | 56 | 0.080 |
Why?
|
Luteal Phase | 1 | 2008 | 28 | 0.080 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2008 | 20 | 0.080 |
Why?
|
Blood Platelets | 1 | 2008 | 41 | 0.080 |
Why?
|
Cost of Illness | 1 | 2008 | 70 | 0.080 |
Why?
|
Administration, Intravaginal | 1 | 2007 | 8 | 0.080 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2007 | 5 | 0.080 |
Why?
|
Tomography, Emission-Computed | 2 | 1998 | 23 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 1998 | 122 | 0.070 |
Why?
|
Telemetry | 1 | 2007 | 27 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 2007 | 32 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2010 | 383 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 422 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 43 | 0.070 |
Why?
|
Radioligand Assay | 1 | 2006 | 25 | 0.070 |
Why?
|
Gyrus Cinguli | 1 | 2006 | 22 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2006 | 56 | 0.070 |
Why?
|
Pyridines | 1 | 2006 | 81 | 0.070 |
Why?
|
Piperazines | 1 | 2006 | 60 | 0.070 |
Why?
|
Amygdala | 1 | 2006 | 60 | 0.070 |
Why?
|
Insulin | 2 | 2019 | 368 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2006 | 94 | 0.070 |
Why?
|
Physical Conditioning, Animal | 2 | 2017 | 32 | 0.060 |
Why?
|
Estrus | 1 | 2005 | 4 | 0.060 |
Why?
|
Blotting, Western | 2 | 2003 | 305 | 0.060 |
Why?
|
Social Dominance | 2 | 2011 | 18 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 849 | 0.060 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2004 | 10 | 0.060 |
Why?
|
Cell Division | 1 | 2004 | 98 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2004 | 44 | 0.060 |
Why?
|
Neurosecretory Systems | 1 | 2004 | 4 | 0.060 |
Why?
|
Linear Models | 2 | 2017 | 454 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2004 | 34 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2004 | 55 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2006 | 911 | 0.060 |
Why?
|
Survival Analysis | 1 | 2005 | 491 | 0.060 |
Why?
|
Densitometry | 1 | 2003 | 8 | 0.060 |
Why?
|
Pineal Gland | 1 | 2003 | 3 | 0.060 |
Why?
|
Citalopram | 1 | 2003 | 6 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2003 | 15 | 0.050 |
Why?
|
Glucocorticoids | 2 | 2011 | 161 | 0.050 |
Why?
|
Phytoestrogens | 1 | 2003 | 17 | 0.050 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2003 | 23 | 0.050 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 16 | 0.050 |
Why?
|
Mesencephalon | 1 | 2003 | 18 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2003 | 30 | 0.050 |
Why?
|
Stereotyped Behavior | 1 | 2002 | 14 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2017 | 4050 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 110 | 0.050 |
Why?
|
Rats | 2 | 2015 | 1675 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2002 | 102 | 0.050 |
Why?
|
Bacteroides | 1 | 2021 | 7 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 8 | 0.050 |
Why?
|
Lactobacillus | 1 | 2021 | 14 | 0.050 |
Why?
|
Feces | 1 | 2021 | 36 | 0.050 |
Why?
|
Age Factors | 2 | 2015 | 1204 | 0.050 |
Why?
|
Genetic Fitness | 1 | 2020 | 2 | 0.050 |
Why?
|
Liver | 1 | 2003 | 486 | 0.050 |
Why?
|
Raphe Nuclei | 1 | 2000 | 1 | 0.050 |
Why?
|
Tryptophan Hydroxylase | 1 | 2000 | 1 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2001 | 176 | 0.050 |
Why?
|
Progestins | 1 | 2000 | 21 | 0.050 |
Why?
|
Self Administration | 1 | 2001 | 303 | 0.040 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2019 | 8 | 0.040 |
Why?
|
Growth Hormone | 1 | 1998 | 13 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 1998 | 30 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2016 | 545 | 0.040 |
Why?
|
Postoperative Period | 1 | 2018 | 100 | 0.040 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1999 | 128 | 0.040 |
Why?
|
Feeding Behavior | 1 | 1999 | 162 | 0.040 |
Why?
|
Middle Aged | 3 | 2015 | 11949 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 1998 | 302 | 0.040 |
Why?
|
Corpus Striatum | 1 | 1998 | 61 | 0.040 |
Why?
|
Pregnanolone | 1 | 1997 | 3 | 0.040 |
Why?
|
Grooming | 1 | 1997 | 2 | 0.040 |
Why?
|
Homozygote | 1 | 2017 | 60 | 0.040 |
Why?
|
Autopsy | 1 | 2017 | 39 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 1997 | 30 | 0.040 |
Why?
|
Prospective Studies | 2 | 2013 | 2274 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2016 | 7 | 0.040 |
Why?
|
Blood Glucose | 1 | 2019 | 496 | 0.040 |
Why?
|
Alleles | 1 | 2017 | 252 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 2016 | 15 | 0.030 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2015 | 6 | 0.030 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2015 | 6 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2015 | 7 | 0.030 |
Why?
|
Interleukin-7 | 1 | 2015 | 11 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2015 | 22 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 29 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 33 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 279 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 28 | 0.030 |
Why?
|
Ketamine | 1 | 2015 | 20 | 0.030 |
Why?
|
Metabolome | 1 | 2015 | 36 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 756 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2015 | 45 | 0.030 |
Why?
|
Cartilage, Articular | 1 | 2015 | 78 | 0.030 |
Why?
|
Social Class | 1 | 2015 | 89 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2014 | 28 | 0.030 |
Why?
|
Animal Experimentation | 1 | 2014 | 6 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 773 | 0.030 |
Why?
|
Radiography | 1 | 2015 | 377 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2015 | 236 | 0.030 |
Why?
|
United States | 2 | 2014 | 3983 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2013 | 31 | 0.030 |
Why?
|
Collagen Type I | 1 | 2013 | 40 | 0.030 |
Why?
|
Leptin | 1 | 2013 | 69 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2013 | 34 | 0.030 |
Why?
|
Astrocytes | 1 | 2013 | 58 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 133 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2013 | 39 | 0.030 |
Why?
|
Isotonic Contraction | 1 | 2012 | 8 | 0.030 |
Why?
|
Myofibrils | 1 | 2012 | 10 | 0.030 |
Why?
|
Norepinephrine | 1 | 2013 | 76 | 0.030 |
Why?
|
Adiponectin | 1 | 2013 | 104 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2015 | 395 | 0.030 |
Why?
|
RNA | 1 | 2013 | 95 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 920 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2013 | 128 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2012 | 69 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 2012 | 89 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 187 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 502 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2013 | 137 | 0.030 |
Why?
|
Macrophages | 1 | 2013 | 194 | 0.020 |
Why?
|
Chronic Disease | 1 | 2013 | 406 | 0.020 |
Why?
|
Skin | 1 | 2013 | 217 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 78 | 0.020 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2010 | 9 | 0.020 |
Why?
|
Survival Rate | 1 | 2013 | 894 | 0.020 |
Why?
|
Receptors, Cholinergic | 1 | 2010 | 22 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 39 | 0.020 |
Why?
|
European Continental Ancestry Group | 1 | 2015 | 1180 | 0.020 |
Why?
|
Risk | 1 | 2010 | 325 | 0.020 |
Why?
|
Mice | 1 | 2015 | 2524 | 0.020 |
Why?
|
Prognosis | 1 | 2013 | 1523 | 0.020 |
Why?
|
Prevalence | 1 | 2011 | 986 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2008 | 32 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 316 | 0.020 |
Why?
|
Hispanic Americans | 1 | 2015 | 949 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 410 | 0.020 |
Why?
|
Adult | 1 | 2021 | 9467 | 0.020 |
Why?
|
Mental Disorders | 1 | 2008 | 119 | 0.020 |
Why?
|
Heart Diseases | 1 | 2008 | 120 | 0.020 |
Why?
|
African Americans | 1 | 2015 | 1443 | 0.020 |
Why?
|
Phylogeny | 1 | 2003 | 56 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 2000 | 16 | 0.010 |
Why?
|
Tamoxifen | 1 | 2000 | 56 | 0.010 |
Why?
|
Problem Solving | 1 | 1999 | 28 | 0.010 |
Why?
|
Diet, Fat-Restricted | 1 | 1999 | 30 | 0.010 |
Why?
|
Basal Ganglia | 1 | 1998 | 14 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1998 | 25 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2000 | 534 | 0.010 |
Why?
|
Benzamides | 1 | 1998 | 53 | 0.010 |
Why?
|
Piperidines | 1 | 1998 | 125 | 0.010 |
Why?
|
Adrenocortical Hyperfunction | 1 | 1996 | 1 | 0.010 |
Why?
|
Ovarian Diseases | 1 | 1996 | 8 | 0.010 |
Why?
|
Causality | 1 | 1996 | 39 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1996 | 600 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1996 | 253 | 0.010 |
Why?
|
Pregnancy | 1 | 1996 | 1010 | 0.010 |
Why?
|